Riskpilot← Back to searchSign inGet full accessSALLINGVEJ DYREKLINIK ApS
APSActiveCVR 29154333Rebildvej 1Veterinary activities · NACE 7500Est. 200519 employees
Revenue 2025
DKK 6,6M
+30% vs 2024
EBITDA margin
7.3%
+7% vs 2024
Equity ratio
44.8%
Financial strength
Net profit 2025
DKK 271K
+5% vs 2024
| Revenue | DKK 6,6M | +30% |
| EBITDA | DKK 482K | +7% |
| Net profit | DKK 271K | +5% |
| Total assets | DKK 2,1M | +13% |
| Equity | DKK 930K | +8% |
| Employees | 19 | — |
Legal name
SALLINGVEJ DYREKLINIK ApS
CVR number
29154333
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
1. november 2005
Share capital
DKK 125.000
Employees
19 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen
sammen med et bestyrelsesmedlem eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive dyreklinik og dermed beslægtet virksomhed.
Address
Rebildvej 1
Phone
+4538869697
Email
post@sallingvej-dyreklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5.247 | 4.530 | 4.860 | 5.076 | 6.594 |
| Staff expenses | -4.226 | -4.915 | -4.664 | -4.625 | -6.112 |
| EBITDA | 1.022 | -385 | 182 | 451 | 482 |
| Depreciation & amort. | -176 | -177 | -140 | -123 | -133 |
| EBIT | 846 | -562 | 43 | 328 | 350 |
| Net financials | -25 | -42 | -1 | 1 | -0 |
| Profit before tax | 821 | -604 | 42 | 329 | 349 |
| Tax | 181 | -133 | 9 | 72 | 79 |
| Net profit | 640 | -471 | 33 | 257 | 271 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.521 | 1.551 | 1.702 | 1.838 | 2.074 |
| Equity | 1.241 | 769 | 802 | 859 | 930 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.224 | 782 | 846 | 916 | 1.072 |
| Total debt | 1.224 | 782 | 846 | 916 | 1.072 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20212025
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20212025
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
20212025
Asset turnover
3.18×
This company
1.12×
Market median
+184% vs market
20212025
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MR Management | Management | 2022 |
| Former (2) | ||
| Audit | 2005 – 2011 | |
PA Management | Management | 2005 – 2005 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2022 | |
| Individual | 10–14.99% | 10–14.99% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øjenpaneldyrlæge Louise Mulvad Holding ApS
SALLINGVEJ DYREKLINIK ApS Board members of SALLINGVEJ DYREKLINIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette Rydahl Jensen | Management | 0 companies |
| GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB | Audit | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Louise Tatiana Malling Mulvad | Chairman | 0 companies |